drugset / Trial / NCT03592121

Study to Investigate the Effect of AB-101 in Breast Cancer Survivors

NCT03592121

Phase 0 Completed 3 enrolled Applied Biology, Inc.
RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this research study is to investigate the possibility that a topical drug could restore nipple sensitivity and improve sexual quality of life in breast cancer survivors.

Timeline

Start
2018-07-09
Primary completion
2019-10-12
Completion
2019-10-12

Drugs

EvaluationDrugModalityDoseRoute
Subject AB-101 Cell therapy Topical